Rita I. Jain's Insider Trades & SAST Disclosures
Rita I. Jain's most recent trade in AnaptysBio Inc was a trade of 16,510 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Rita I. Jain.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 4,534 | 4,534 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Rita I. Jain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 3,234 | 0 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 1,300 | 0 | - | - | Restricted Stock Unit | |
| Celldex Therapeutics Inc. | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,500 | 16,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| AnaptysBio Inc | Jain Rita I. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | I. Rita Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 8,015 | 8,015 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,234 | 3,234 | - | - | Restricted Stock Unit | |
| Celldex Therapeutics Inc. | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 17,100 | 17,100 | - | - | Non-Qualified Stock Option (right to buy) | |
| Immunovant Inc | Rita I. Jain | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 342,300 | 342,300 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Rita I. Jain | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 97,600 | 117,600 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Rita I. Jain | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 11,765 | 129,365 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Rita I. Jain | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 220,000 | 220,000 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Rita I. Jain | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges